Clinical Trial Update: Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating iloprost for managing vaso-occlusive crises in adults with sickle cell disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Vaso-Occlusive Crises, Sickle Cell Disease | Phase 3 | Status: NOT_YET_RECRUITING